News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Memphasys.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Memphasys tumbles almost 30pc after cow pregnancy trial disappoints
News
Top 10 at 10: Data stock on the rise as Domino’s gets burnt, cattle inseminator shoots blanks
News
In Case You Missed It: Lithium, chocolate and an IVF tech distribution deal
News
Closing Bell: ASX surges late as weak China PMIs smell a lot like pre-stimmy
Health & Biotech
ASX Health Stocks: Memphasys reports 10 new live births in India using its Felix System
Health & Biotech
ASX Health Stocks: Firebrick achieves primary endpoint in Phase 2; Memphasys surges 20pc on Japan deal
News
Top 10 at 10: Lithium Australia hops into bed with big gun Mineral Resources
News
Market Highlights: Wall Street megacaps slip, China’s deflation, and best day to buy Bitcoin
Health & Biotech
ASX Health Stocks: Memphasys says Felix can separate sperm better than current techniques
Health & Biotech
ASX Health Stocks: PYC to take second asset to clinical trial; FDA sees no issues in Botanix submission
News
Market Highlights: ASX to rise again, oil prices spike 7pc, and 5 small caps to watch on Monday
Health & Biotech
ASX Health Stocks: Creso eyes psychedelic spinout off the back of landmark TGA decision
Health & Biotech
ASX Health Stocks: Memphasys plans in vivo studies in Japan, Canada; ECS sells Tassie assets
News
Market Highlights: Wall St’s big rally, Budget week, and 5 ASX small caps to watch on Monday
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: ASX 200 sinks, jobless rate hits a 48-year low
News